Stock Markets July 7, 2026 10:35 AM

Applied Materials and Micron Lead Declines Among Broad Set of Market Movers

Stocks from mega-caps to small-caps saw sharp moves Tuesday, with notable weakness in semiconductors and mixed results in mid- and small-cap names

By Avery Klein
Share
Twitter Reddit Facebook LinkedIn
AMAT MU RIVN INIO

Tuesday's session produced pronounced volatility across market-cap tiers. Mega-cap technology names applied materials and micron technology fell sharply, while a range of large-, mid- and small-cap equities posted double-digit moves in both directions. Several corporate-specific headlines accompanied the swings, including a public offering by an automaker and regulatory and analyst actions affecting biopharma and specialty software names.

Applied Materials and Micron Lead Declines Among Broad Set of Market Movers
AMAT MU RIVN INIO
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Mega-cap semiconductors and technology names experienced notable declines, led by AMAT (-10.28%) and MU (-8.27%).
  • Large- and mid-cap groups showed multiple double-digit movers, with corporate actions such as a public offering and analyst rating changes evident among catalysts.
  • Small-cap equities displayed elevated volatility with steep declines and some positive moves tied to specific company developments.

Equity markets on Tuesday registered significant intraday swings, with several well-known names among the steepest decliners and a handful of smaller issuers showing large percentage gains. Semiconductor-related names were prominent among the weakness, while activity extended across automotive, materials, therapeutics and various small-cap listings.

Below are the most notable movers organized by market-cap band, using the market-cap designations supplied for this session.


Mega-Cap Movers (Market Cap: $200 billion USD or higher)

  • Applied Matls Inc (AMAT): -10.28%
  • Micron Tech (MU): -8.27%

Large-Cap Stock Movers (Market Cap: $10-$200 billion USD)

  • Rivian Automotive (RIVN); Rivian launches public offering of 75 million stocks: -12.98%
  • Innio Holding Gmbh (INIO): -11.81%
  • Astera Labs (ALAB): -11.75%
  • Allegro Microsystems Inc (ALGM): -10.27%
  • Entegris Inc. (ENTG): -9.38%
  • Cerebras Systems Inc (CBRS): -7.6%

Mid-Cap Stock Movers (Market Cap: $2-$10 billion USD)

  • Crinetics Pharmaceuticals Inc (CRNX); Cantor Fitzgerald downgrades Crinetics stock rating after Vertex deal: +98.75%
  • MUU (MUU): -16.23%
  • Ichor Holdings Ltd (ICHR): -12.37%
  • Ultra Clean Holdings (UCTT): -13.5%
  • Kulicke and Soffa (KLIC): -10.46%
  • SNXX (SNXX): -24.24%
  • Puyi ADR (MAAS): +18.61%
  • Agios Pharm (AGIO); FDA accepts Agios sNDA for mitapivat in sickle cell disease: +11.42%

Small-Cap Stock Movers (Market Cap: $300 million - $2 billion USD)

  • INTW (INTW): -20.52%
  • Cantor Equity Partners II Inc (SECZ): -18.11%
  • MULL (MULL): -16.72%
  • A Paradise Acquisition (ENHA): +9.92%
  • ASTX NYSE (ASTX): -1.67%

The session was characterized by concentrated selling in several technology and semiconductor-related names at the top end of the market-cap scale, while mid-cap and small-cap lists exhibited both dramatic declines and outsized percentage gains tied to company-specific developments. Analyst action and regulatory acceptance were among the cited catalysts for individual mid-cap moves; an issuance of new stock was recorded for one large-cap automotive firm.

Key takeaways:

  • Semiconductor and technology stocks led losses among mega-cap names, with Applied Matls Inc (AMAT) down 10.28% and Micron Tech (MU) down 8.27%.
  • Large-cap and mid-cap groups saw multiple double-digit percentage moves, both negative and positive, often tied to corporate announcements such as a public offering or analyst rating actions.
  • Small-cap volatility remained elevated, with several names moving more than 15% in either direction.

Risks and uncertainties noted in the session:

  • Company-specific corporate actions, such as the public offering by Rivian Automotive, can create sizable downward pressure on the issuer and related peer valuation dynamics.
  • Analyst downgrades or changes in rating, exemplified by the Cantor Fitzgerald action on Crinetics, can produce large swings in mid-cap healthcare equities.
  • Regulatory developments, such as acceptance of supplemental filings, can create significant positive repricing for affected biopharma names, while other sectors face selling absent similar news.

Market participants monitoring these moves should note the mix of headline-driven reactions and cross-sector participation in today's price action. The list above reflects the largest percentage changes reported across market-cap tiers for the session and includes both declines and gains that were material in magnitude.

Risks

  • Equity prices can be materially affected by company-specific corporate actions, such as public offerings - relevant to the automotive sector and broader equity markets.
  • Analyst downgrades can trigger sharp re-pricing in mid-cap healthcare names, presenting heightened risk for investors in that sector.
  • Regulatory decisions or acceptance of filings can cause outsized moves in biopharma stocks, creating uncertainty for market participants in that sector.

More from Stock Markets

Airbus and MTU to Form Joint Venture for Hydrogen Fuel Cell Aircraft Engine Jul 7, 2026 Ukraine Prioritizes AI Models It Can Host Locally to Preserve Control Jul 7, 2026 NATO Moves to Expand ISR Fleet with Intent to Acquire Northrop Grumman Triton Jul 7, 2026 Thomson Reuters Shares Jump as Legal Teams Embrace AI Tools Jul 7, 2026 Big Tech Leans on Bonds and Stock Sales to Finance AI and Cloud Buildouts Jul 7, 2026